Page results
-
Tens of thousands of people in England who have hepatitis C could now get tested and treated thanks to a new mobile health unit arriving to coincide with World Hepatitis Day on 28 July.
-
The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
-
Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.
-
A second mass vaccination event will be held over four days this month at Emirates Stadium in a bid to give thousands more people the chance to have their first or second dose of the Pfizer Covid-19 vaccine.
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms
-
Today, 11 February, marks the tenth anniversary of the International Day of Women and Girls in Science, which seeks to bring gender equality in science and promote role models to inspire girls and women into scientific professions.
-
Our outpatient clinics will remain predominantly virtual throughout the COVID-19 pandemic. Please continue to refer via the NHS e-referral service.
File results
-
FOI/2023/0522 - Urology cancer pathway
-
FOI/2023/0523 - Treatment on Nivolumab
-
FOI/2023/0537 - Agency usage for the Occupational Therapy
-
FOI/2023/0542 - Pulmonary rehabilitation (PR)
-
FOI/2023/0550 - Varicose veins referrals, treatment and wait time
-
FOI/2023/0553 - Maternity complaints by ethnicity
-
FOI/2023/0559 - Patients admitted to hospital with dental distress
-
FOI/2023/0560 - Digital maternity training platform
-
FOI/2023/0561 - Birthrate Plus
-
FOI/2023/0563 - Treatment for Haemophilia B and Von Willebrand disease